- Title
-
Modulation of behavioral and neurochemical responses of adult zebrafish by fluoxetine, eicosapentaenoic acid and lipopolysaccharide in the prolonged chronic unpredictable stress model
- Authors
- Demin, K.A., Kolesnikova, T.O., Galstyan, D.S., Krotova, N.A., Ilyin, N.P., Derzhavina, K.A., Levchenko, N.A., Strekalova, T., de Abreu, M.S., Petersen, E.V., Seredinskaya, M., Cherneyko, Y.V., Kositsyn, Y.M., Sorokin, D.V., Zabegalov, K.N., Mor, M.S., Efimova, E.V., Kalueff, A.V.
- Source
- Full text @ Sci. Rep.
A brief diagram outlining the study experimental design, including the prolonged 11-week chronic unpredictable stress (PCUS) protocol and behavioral testing battery (see Table |
Behavioral alterations induced by prolonged chronic unpredictable stress (PCUS) exposure and fluoxetine, EPA, or LPS treatment in adult zebrafish tested in the novel tank test. Data are presented as median and Q1, Q3 (n = 12–22 per group). * |
Behavioral alterations induced by prolonged chronic unpredictable stress (PCUS) exposure and fluoxetine, EPA, or LPS treatment in adult zebrafish tested in the shoaling test (ST; inter-fish distance) and conditioned place avoidance (CPA, time spent in the light compartment). Data are presented as median and Q1, Q3 (total number of still images: 198–541 per group for ST (calculated as distances between each zebrafish in each captured still image, thus representing the number of images taken), n = 12–22 per group for CPA). * |
Neurochemical alterations induced by the prolonged chronic unpredictable stress (PCUS) exposure and fluoxetine, EPA, or LPS treatment in adult zebrafish brain assessed using HPLC. Data are presented as median and Q1, Q3 (n = 12 per group). *p < 0.05, **p < 0.01 vs. control, post-hoc Dunn’s test for significant Kruskal–Wallis data. Graphs were constructed using the ggplot2 R package30, also see Table 2 and Supplementary Table S2 for statistical details. Groups: C control, S PCUS, F fluoxetine, E eicosapentaenoic acid (EPA), L lipopolysaccharide (LPS). |